The impact of symptom severity on the humanistic and economic burden of inflammatory bowel disease: a real-world data linkage study

References

• Sairenji T, Collins KL, Evans DV. An update on inflammatory bowel disease. Prim Care. 2017;44(4):673–692.
   PubMed Web of Science ®Google Scholar
• Chen X-L, Zhong L, Wen Y, et al. Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties. Heal Qual Life Outcomes. 2017;15:177.
   PubMed Web of Science ®Google Scholar
• Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life. 2019;12(2):113–122.
   PubMedGoogle Scholar
• Waterman M, Xu W, Stempak JM, et al. Distinct and overlapping genetic loci in Crohn’s disease and ulcerative colitis: correlations with pathogenesis. Inflamm Bowel Dis. 2011;17(9):1936–1942.
   PubMed Web of Science ®Google Scholar
• Su HJ, Chiu YT, Chiu CT, et al. Inflammatory bowel disease and its treatment in 2018: global and Taiwanese status updates. J Formos Med Assoc. 2019;118(7):1083–1092.
   PubMed Web of Science ®Google Scholar
• Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002;15(1):79–94.
   PubMed Web of Science ®Google Scholar
• Perler B, Ungaro R, Baird G, et al. Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort. BMC Gastroenterol. 2019;19(1):47.
   PubMed Web of Science ®Google Scholar
• Alatab S, Sepanlou SG, Ikuta K, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(1):17–30.
   PubMed Web of Science ®Google Scholar
• Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–727.
   PubMed Web of Science ®Google Scholar
• Xu F, Dahlhamer JM, Zammitti EP, et al. Health-Risk behaviors and chronic conditions among adults with inflammatory bowel disease — United States, 2015 and 2016. MMWR Morb Mortal Wkly Rep. 2018;67(6):190–195.
   PubMed Web of Science ®Google Scholar
• Fu H, Kaminga AC, Peng Y, et al. Associations between disease activity, social support and health-related quality of life in patients with inflammatory bowel diseases: the mediating role of psychological symptoms. BMC Gastroenterol. 2020;20(1):11.
   PubMed Web of Science ®Google Scholar
• Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135(6):1907–1913.
   PubMed Web of Science ®Google Scholar
• Nellesen D, Yee K, Chawla A, et al. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. JMCP J. Manag. Care Pharm. 2013;19:755–764.
   PubMed Web of Science ®Google Scholar
• Park KT, Ehrlich OG, Allen JI, et al. The cost of inflammatory bowel disease: an initiative from the Crohn's & Colitis Foundation. Inflamm Bowel Dis. 2020;26(1):1–10.
   PubMed Web of Science ®Google Scholar
• Kawalec P. Indirect costs of inflammatory bowel diseases: Crohn's disease and ulcerative colitis. A systematic review. Arch Med Sci. 2016;12(2):295–302.
   PubMed Web of Science ®Google Scholar
• Karina R, Teresa M, Natalia F. The economic burden associated with inflammatory bowel disease severity. Am J Gastroenterol. 2018;113:S11.
   Web of Science ®Google Scholar
• Long GH, Tatro AR, Oh YS, et al. Analysis of safety, medical resource utilization, and treatment costs by drug class for management of inflammatory bowel disease in the United States based on insurance claims data. Adv Ther. 2019;36(11):3079–3095.
   PubMed Web of Science ®Google Scholar
• Nguyen GC, Chong CA, Chong RY. National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States. J Crohns Colitis. 2014;8(4):288–295.
   PubMed Web of Science ®Google Scholar
• Ware JE, Snow KK, Kosinski M, et al. SF-36 Health survey: manual and interpretation guide. Lincoln (RI): Quality Metric Incorporated; 2000.
   Google Scholar
• Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–292.
   PubMed Web of Science ®Google Scholar
• Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736.
   PubMed Web of Science ®Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353–365.
   PubMed Web of Science ®Google Scholar
• DiBonaventura M, Gupta S, McDonald M, et al. Impact of self-rated osteoarthritis severity in an employed population: cross-sectional analysis of data from the national health and wellness survey. Health Qual Life Outcomes. 2012;10(1):30.
   PubMed Web of Science ®Google Scholar
• DiBonaventura M. D, Gupta S, McDonald M, et al. Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the national health and wellness survey. BMC Musculoskelet Disord. 2011;12(1):83.
   PubMed Web of Science ®Google Scholar
• Habibi F, Habibi M, Gharavinia A, et al. Quality of life in inflammatory bowel disease patients: a cross-sectional study. J Res Med Sci. 2017;22(1):104.
   PubMed Web of Science ®Google Scholar
• Magalhães J, de Castro FD, Carvalho PB, et al. Quality of life in patients with inflammatory bowel disease: importance of clinical, demographic and psychosocial factors. Arq Gastroenterol. 2014;51(3):192–197.
   PubMedGoogle Scholar
• Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14(6):1523–1532.
   PubMed Web of Science ®Google Scholar
• Hagelund LM, Elkjaer Stallknecht S, Jensen HH. Quality of life and patient preferences among Danish patients with ulcerative colitis – results from a survey study. Curr Med Res Opin. 2020;36(5):771–779.
   PubMed Web of Science ®Google Scholar
• Armuzzi A, Tarallo M, Lucas J, et al. The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe. BMC Gastroenterol. 2020;20(1):18.
   PubMed Web of Science ®Google Scholar
• Gray WN, Denson LA, Baldassano RN, et al. Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(7):1581–1586.
   PubMed Web of Science ®Google Scholar
• Williet N, Sarter H, Gower-Rousseau C, et al. Patient-reported outcomes in a French nationwide survey of inflammatory bowel disease patients. ECCOJC. 2017;11(2):165–174.
   Web of Science ®Google Scholar
• Gibson PR, Vaizey C, Black CM, et al. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study. J Crohn’s Colitis. 2014;8(7):598–606.
   Google Scholar
• Holko P, Kawalec P, Mossakowska M, et al. Health-Related quality of life impairment and indirect cost of Crohn’s disease: a self-report study in Poland. Green J, editor. PLOS One. 2016;11(12):e0168586.
   PubMed Web of Science ®Google Scholar
• Bruno M, Castaño A, Burton A, et al. Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges. Heart Fail Rev. 2021;26(1):35–45.
   PubMed Web of Science ®Google Scholar
• Longobardi T, Jacobs P, Bernstein CN. Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol. 2003;98(5):1064–1072.
   PubMed Web of Science ®Google Scholar
• Rezaie A, Quan H, Fedorak RN, et al. Development and validation of an administrative case definition for inflammatory bowel diseases. Can J Gastroenterol. 2012;26(10):711–717.
   PubMed Web of Science ®Google Scholar
• Keyashian K, Dehghan M, Sceats L, et al. Comparative incidence of inflammatory bowel disease in different age groups in the United States. Inflamm Bowel Dis. 2019;25(12):1983–1989.
   PubMed Web of Science ®Google Scholar
• Sewell JL, Yee HF. 13-year mortality trends among hospitalized patients with inflammatory bowel disease. BMC Gastroenterol. 2012;12(1):79.
   PubMed Web of Science ®Google Scholar